Ursodeoxycholic acid (UDCA) is widely used for the treatment of chronic cholestatic liver diseases. However, a recent randomized, controlled trial has surprisingly shown that the use of high-dose ...

为探究 UDCA 对肥胖、高血压等慢性疾病的影响，相关研究人员开展关于 UDCA 对人体测量指标、血压和炎症影响的研究，发现其可改善 BMI 和 DBP，但会升高 SBP。该研究为临床治疗提供参考，推荐科研读者阅读。 在当今社会，肥胖、高血压和代谢综合征等慢性疾病 ...

Methods: Retrospective review on all patients currently receiving UDCA. Dose and duration of UDCA was recorded. Mode of diagnosis for CFALD was also noted. LFT and USS were analyzed with changes ...

Shilpa Medicare Ltd. had earlier completed phase-3 clinical studies of this novel product SMLNUD07 - Nor Ursodeoxycholic Acid (Nor UDCA) tablets - and presented the results of the trial titled ...